<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Protein Cell</journal-id><journal-id journal-id-type="iso-abbrev">Protein Cell</journal-id><journal-id journal-id-type="publisher-id">proteincell</journal-id><journal-title-group><journal-title>Protein &#x00026; Cell</journal-title></journal-title-group><issn pub-type="ppub">1674-800X</issn><issn pub-type="epub">1674-8018</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>US</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39252612</article-id><article-id pub-id-type="pmc">PMC11786723</article-id>
<article-id pub-id-type="doi">10.1093/procel/pwae049</article-id><article-id pub-id-type="publisher-id">pwae049</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/SCI00960</subject></subj-group></article-categories><title-group><article-title>Endoplasmic reticulum membrane remodeling by targeting reticulon-4 induces pyroptosis to facilitate antitumor immune</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Mei-Mei</given-names></name><aff>
<institution>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University</institution>, <addr-line>Beijing 100191</addr-line>, <country country="CN">China</country></aff><xref rid="fn-0001" ref-type="author-notes"/></contrib><contrib contrib-type="author"><name><surname>Ren</surname><given-names>Ting-Ting</given-names></name><aff>
<institution>Beijing Key Laboratory of Musculoskeletal Tumor, Peking University People&#x02019;s Hospital</institution>, <addr-line>Beijing 100044</addr-line>, <country country="CN">China</country></aff><xref rid="fn-0001" ref-type="author-notes"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Jing-Kang</given-names></name><aff>
<institution>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University</institution>, <addr-line>Beijing 100191</addr-line>, <country country="CN">China</country></aff></contrib><contrib contrib-type="author"><name><surname>Yao</surname><given-names>Lu</given-names></name><aff>
<institution>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University</institution>, <addr-line>Beijing 100191</addr-line>, <country country="CN">China</country></aff></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Ting-Ting</given-names></name><aff>
<institution>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University</institution>, <addr-line>Beijing 100191</addr-line>, <country country="CN">China</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Ji-Chao</given-names></name><aff>
<institution>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University</institution>, <addr-line>Beijing 100191</addr-line>, <country country="CN">China</country></aff></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yang</given-names></name><aff>
<institution>Center of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital</institution>, <addr-line>Beijing 100191</addr-line>, <country country="CN">China</country></aff></contrib><contrib contrib-type="author"><name><surname>Yuan</surname><given-names>Lan</given-names></name><aff>
<institution>Proteomics Laboratory, Medical and Healthy Analytical Center, Peking University Health Science Center</institution>, <addr-line>Beijing 100191</addr-line>, <country country="CN">China</country></aff></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Dan</given-names></name><aff>
<institution>Proteomics Laboratory, Medical and Healthy Analytical Center, Peking University Health Science Center</institution>, <addr-line>Beijing 100191</addr-line>, <country country="CN">China</country></aff></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Jiu-Hui</given-names></name><aff>
<institution>Beijing Key Laboratory of Musculoskeletal Tumor, Peking University People&#x02019;s Hospital</institution>, <addr-line>Beijing 100044</addr-line>, <country country="CN">China</country></aff></contrib><contrib contrib-type="author"><name><surname>Tu</surname><given-names>Peng-Fei</given-names></name><aff>
<institution>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University</institution>, <addr-line>Beijing 100191</addr-line>, <country country="CN">China</country></aff></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Tang</surname><given-names>Xiao-Dong</given-names></name><aff>
<institution>Beijing Key Laboratory of Musculoskeletal Tumor, Peking University People&#x02019;s Hospital</institution>, <addr-line>Beijing 100044</addr-line>, <country country="CN">China</country></aff><xref rid="c1" ref-type="corresp"/><!--tangxiaodong@pkuph.edu.cn--></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1082-6327</contrib-id><name><surname>Zeng</surname><given-names>Ke-Wu</given-names></name><aff>
<institution>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University</institution>, <addr-line>Beijing 100191</addr-line>, <country country="CN">China</country></aff><xref rid="c2" ref-type="corresp"/><!--ZKW@bjmu.edu.cn--></contrib></contrib-group><author-notes><fn id="fn-0001"><p>Mei-Mei Zhao and Ting-Ting Ren contributed equally to this work.</p></fn><corresp id="c1">Correspondence: <email>tangxiaodong@pkuph.edu.cn</email></corresp><corresp id="c2">Correspondence: <email>ZKW@bjmu.edu.cn</email></corresp></author-notes><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><pub-date pub-type="epub" iso-8601-date="2024-09-10"><day>10</day><month>9</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>9</month><year>2024</year></pub-date><volume>16</volume><issue>2</issue><fpage>121</fpage><lpage>135</lpage><history><date date-type="received"><day>19</day><month>4</month><year>2024</year></date><date date-type="accepted"><day>12</day><month>8</month><year>2024</year></date><date date-type="corrected-typeset"><day>31</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024. Published by Oxford University Press on behalf of Higher Education Press.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="pwae049.pdf"/><abstract><title>Abstract</title><p>Pyroptosis is an identified programmed cell death that has been highly linked to endoplasmic reticulum (ER) dynamics. However, the crucial proteins for modulating dynamic ER membrane curvature change that trigger pyroptosis are currently not well understood. In this study, a biotin-labeled chemical probe of potent pyroptosis inducer &#x003b1;-mangostin (&#x003b1;-MG) was synthesized. Through protein microarray analysis, reticulon-4 (RTN4/Nogo), a crucial regulator of ER membrane curvature, was identified as a target of &#x003b1;-MG. We observed that chemically induced proteasome degradation of RTN4 by &#x003b1;-MG through recruiting E3 ligase UBR5 significantly enhances the pyroptosis phenotype in cancer cells. Interestingly, the downregulation of RTN4 expression significantly facilitated a dynamic remodeling of ER membrane curvature through a transition from tubules to sheets, consequently leading to rapid fusion of the ER with the cell plasma membrane. In particular, the ER-to-plasma membrane fusion process is supported by the observed translocation of several crucial ER markers to the &#x0201c;bubble&#x0201d; structures of pyroptotic cells. Furthermore, &#x003b1;-MG-induced RTN4 knockdown leads to pyruvate kinase M2 (PKM2)-dependent conventional caspase-3/gasdermin E (GSDME) cleavages for pyroptosis progression. <italic toggle="yes">In vivo</italic>, we observed that chemical or genetic RTN4 knockdown significantly inhibited cancer cells growth, which further exhibited an antitumor immune response with anti-programmed death-1 (anti-PD-1). In translational research, RTN4 high expression was closely correlated with the tumor metastasis and death of patients. Taken together, RTN4 plays a fundamental role in inducing pyroptosis through the modulation of ER membrane curvature remodeling, thus representing a prospective druggable target for anticancer immunotherapy.</p></abstract><kwd-group><kwd>pyroptosis</kwd><kwd>ER membrane</kwd><kwd>antitumor immune</kwd><kwd>osteosarcoma</kwd><kwd>chemical degrader</kwd><kwd>reticulon-4 (RTN4)</kwd></kwd-group><funding-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>National Natural Sciences Foundation of China</institution></institution-wrap>
</funding-source><award-id>82325050</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>National Key R&#x00026;D Program of China</institution><institution-id institution-id-type="DOI">10.13039/501100012166</institution-id></institution-wrap>
</funding-source><award-id>2022YFC3501601</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Jinan New 20 Policies for Higher Education Funding</institution></institution-wrap>
</funding-source><award-id>202228048</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Natural Science Foundation of Shandong Province</institution><institution-id institution-id-type="DOI">10.13039/501100007129</institution-id></institution-wrap>
</funding-source><award-id>ZR2022LZY021</award-id></award-group></funding-group><counts><page-count count="15"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Endoplasmic reticulum (ER) is a crucial organelle that decides cell fates via the quality control of functional proteins (<xref rid="CIT0011" ref-type="bibr">Hetz and Papa, 2018</xref>; <xref rid="CIT0025" ref-type="bibr">Lin et al., 2007</xref>). A recent breakthrough in ER biology is the discovery of ER dysfunction as a critical molecular event in the occurrence of various programmed cell death including pyroptosis (<xref rid="CIT0007" ref-type="bibr">Chen et al., 2019</xref>; <xref rid="CIT0021" ref-type="bibr">Lebeaupin et al., 2015</xref>; <xref rid="CIT0022" ref-type="bibr">Li et al., 2020</xref>; <xref rid="CIT0046" ref-type="bibr">Zhang et al., 2021</xref>). Particularly, several studies have demonstrated a potential role of ER in triggering pyroptosis via NOD-like receptor protein 3 (NLRP3) inflammasome-mediated mechanism (<xref rid="CIT0016" ref-type="bibr">Ke et al., 2020</xref>; <xref rid="CIT0038" ref-type="bibr">Wang et al., 2020</xref>). Meanwhile, co-location of ER markers C/EBP homologous protein (CHOP) and immunoglobulin heavy chain binding protein (BIP) with pyroptosis markers has also been reported (<xref rid="CIT0045" ref-type="bibr">Zeng et al., 2020</xref>). However, to date, the detailed biological mechanisms responsible for driving ER-associated pyroptosis have not been fully clarified (<xref rid="CIT0015" ref-type="bibr">Kayagaki et al., 2021</xref>).</p><p>Numerous lines of evidence support the concept that pyroptotic cells form typical &#x0201c;bubble&#x0201d; structures by cell-surface remodeling (<xref rid="CIT0044" ref-type="bibr">Yu et al., 2021</xref>). Since the maintenance of ER function necessitates an intact membrane system, the highly dynamic nature of the ER as an extensive membrane system suggests a fundamental potential in the aberrant cell membrane changes, such as the specific &#x0201c;bubble&#x0201d; membrane structures during pyroptosis. In particular, mechanistic studies have elucidated that ER membrane curvature intricately controls the transition of ER morphology from tubules to sheets, thereby facilitating ER stress response and the establishment of intracellular interactions with neighboring organelles, ultimately impacting cellular homeostasis (<xref rid="CIT0031" ref-type="bibr">Puhka et al., 2012</xref>; <xref rid="CIT0040" ref-type="bibr">Westrate et al., 2015</xref>). However, the precise molecular mechanism of ER membrane dynamics change during pyroptosis is currently not well understood. Meanwhile, the specific functional proteins that are engaged in remodeling ER membrane curvature to drive pyroptosis have yet to be fully characterized.</p><p>Reticulons (RTNs) are a specific class of crucial ER curvature stabilizing proteins encoded by four genes in mammals (RTN1-4) (<xref rid="CIT0009" ref-type="bibr">Diekmann et al., 2005</xref>). RTNs mainly localize to ER tubules and the curved edges of ER sheets for cisternae structure stabilization (<xref rid="CIT0002" ref-type="bibr">Breeze et al., 2016</xref>; <xref rid="CIT0013" ref-type="bibr">Joshi et al., 2016</xref>; <xref rid="CIT0034" ref-type="bibr">Shibata et al., 2010</xref>). Besides, RTNs have been reported to maintain ER network structure, protein secretion, and transporting ER constituents (<xref rid="CIT0036" ref-type="bibr">Voeltz et al., 2006</xref>; <xref rid="CIT0041" ref-type="bibr">Wu and Voeltz, 2021</xref>). Particularly, recent reports show that RTNs are widely involved in a range of cell fates determination such as apoptosis, autophagy, and inflammation response, hinting that RTNs may serve as a potential regulator in controlling crucial cellular physiological processes (<xref rid="CIT0004" ref-type="bibr">Carter et al., 2022</xref>; <xref rid="CIT0027" ref-type="bibr">Lorenzo et al., 2011</xref>; <xref rid="CIT0042" ref-type="bibr">Xiao et al., 2022</xref>). Previous reports have shown that targeting RTN4 with chemical small molecules can impair ER and nuclear envelope morphology in cancer cells. However, it is not yet clear whether these compounds can induce cell pyroptosis by regulating ER membrane dynamics. Therefore, it is essential to conduct in-depth biological functional studies using specific small molecule probes targeting RTN4 to elucidate the precise role of RTN4 in the dynamics of the ER membrane changes during pyroptosis.</p><p>In this study, we first identified &#x003b1;-mangostin (&#x003b1;-MG) as a potent chemical inducer of cell pyroptosis. Then, we prepared the biotin-labeled probe for &#x003b1;-MG and revealed that ER-shaping protein RTN4 as a crucial cellular target in controlling pyroptosis progression via chemical genetics strategy. Unexpectedly, &#x003b1;-MG induces the degradation of RTN4 through a mechanism similar to molecular glue, recruiting the E3 ligase ubiquitin protein ligase E3 component N-recognin 5 (UBR5). Then, we found that chemical or genetic RTN4 knockdown significantly promoted dynamic ER membrane curvature remodeling via tubules-to-sheets transition. Of note, RTN4 deficiency significantly induced the ER-plasma membrane fusion to drive the typical &#x0201c;bubble&#x0201d; structures formation in pyroptotic cells. Furthermore, these observations were supported by the high expression of several ER markers in &#x0201c;bubble&#x0201d; structures. <italic toggle="yes">In vivo</italic>, RTN4 knockdown exerted a promising effect to activate antitumor immunity. Meanwhile, high RTN4 expression has been confirmed in individuals with osteosarcoma as potential therapeutic target or biomarker.</p><p>Collectively, our findings reveal that RTN4 contributes to progress of pyroptosis via morphological alterations of ER membrane curvature, which represents a fundamental target in drug development for anticancer therapeutics.</p></sec><sec id="s2"><title>Results</title><sec id="s3"><title>Discovery of RTN4 as a functional protein in pyroptosis</title><p>Chemical genetics is a crucial strategy to discover functional proteins by using bioactive small molecules as chemical tools (<xref rid="CIT0003" ref-type="bibr">Carlson and White, 2011</xref>; <xref rid="CIT0010" ref-type="bibr">Gangadhar and Stockwell, 2007</xref>). Through pyroptosis phenotype-based high-content screening, we first identified &#x003b1;-mangostin (&#x003b1;-MG), a natural-derived xanthone derivative (<xref rid="CIT0006" ref-type="bibr">Chen et al., 2018</xref>), as an available chemical probe to induce potent pyroptosis phenotype (<xref rid="F1" ref-type="fig">Figs. 1A</xref> and <xref rid="sup1" ref-type="supplementary-material">S1A</xref>). Here, we selected osteosarcoma cells with the most prominent phenotype change for further study. We observed that &#x003b1;-MG concentration- and time-dependently increased the proportion of pyroptosis by Annexin V-PI double staining (<xref rid="F1" ref-type="fig">Fig. 1B</xref>), flow quantitative analysis (<xref rid="F1" ref-type="fig">Fig. 1C</xref>), and lactate dehydrogenase (LDH) release assay (<xref rid="F1" ref-type="fig">Fig. 1D</xref>) in U2OS cells. Immunoblot analysis also confirmed that &#x003b1;-MG induced a typical cleavage of GSDME by caspase-3 (<xref rid="F1" ref-type="fig">Fig. 1E</xref>), indicating an effective chemical tool for interrogating pyroptosis biology. Specifically, to investigate whether GSDME-mediated pyroptosis is the predominant mechanism of cell death induced by &#x003b1;-MG, we conducted knockdown experiments utilizing small interfering RNA (siRNA) to effectively suppress the expression of GSDME. As shown in <xref rid="F1" ref-type="fig">Fig. 1F&#x02013;H</xref>, silencing of GSDME resulted in a significant reversal of &#x003b1;-MG-induced pyroptotic bodies formation and LDH release, indicating a dependence on GSDME for pyroptosis.</p><fig position="float" id="F1"><label>Figure 1.</label><caption><p>Discovery of RTN4 as a functional protein in pyroptosis. (A) High content screening of natural compound library containing 1,370 small molecules based on pyroptotic signatures in U2OS cells identified &#x003b1;-MG as an available chemical probe to induce cell pyroptosis. Ratio of pyroptosis phenotype (%) refers to the total number of cells with bubbles by the total number of cells. (B) &#x003b1;-MG-induced pyroptotic morphology as evidenced by Annexin V-PI double staining (scale bar: 25 &#x003bc;m). (C) &#x003b1;-MG increased the ratio of pyroptotic cells by Annexin V-PI flow analysis. (D) &#x003b1;-MG promoted the release of LDH. (E) &#x003b1;-MG-induced caspase-3 activation and GSDME cleavage by immunoblot assay. (F) GSDME expression was detected by immunoblot after GSDME knockdown. (G) GSDME knockdown inhibited &#x003b1;-MG-induced pyroptosis by Annexin V-PI double staining (scale bar: 25 &#x003bc;m). (H) LDH release assay confirmed that GSDME knockdown reversed &#x003b1;-MG-induced pyroptosis in U2OS cells. (I) Schematic diagram of &#x003b1;-MG-binding proteins identification with the human proteome microarray. (J) A total of 416 &#x003b1;-MG-binding proteins with SNR greater than 1.5 were identified. RTN4 had the highest SNR. (K) The interaction of &#x003b1;-MG with RTN4 isoforms was examined by competitive pull-down assay. (L) The binding of &#x003b1;-MG to RTN4 was determined by MST. (M) Molecular docking of &#x003b1;-MG towards RTN4. Data were presented as mean&#x02005;&#x000b1;&#x02005;SD for three individual experiments. *<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;0.05, **<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;0.01 vs. control group.</p></caption><graphic xlink:href="pwae049_fig1" position="float"/></fig><p>Additionally, we detected the expression levels of GSDME in different osteosarcoma cells (U2OS, HOS, and 143B) and normal osteoblast cell line MC3T3, as well as clinical osteosarcoma samples. As shown in <xref rid="sup1" ref-type="supplementary-material">Fig. S1B</xref>, the expressions of GSDME in these osteosarcoma cells are significantly higher than the control MC3T3 cells, indicating that osteosarcoma potentially comprises a cellular subset demonstrating elevated GSDME expression levels. Meanwhile, the presence of GSDME levels was observed in clinical osteosarcoma samples, confirming the outcomes of cell culture investigations (<xref rid="sup1" ref-type="supplementary-material">Fig. S1B</xref>). Furthermore, we detected GSDME expression in paraffin-embedded specimens gathered from 102 patients with primary osteosarcoma by immunohistochemistry. The results revealed a high expression in osteosarcoma compared with para-tumor tissue. In particular, the high levels of GSDME in osteosarcoma tissues were positively associated with tumor metastasis and death of patients within 3 years (<xref rid="sup1" ref-type="supplementary-material">Fig. S1C&#x02013;E</xref>). Meanwhile, the levels of caspase-3 in osteosarcoma tissues did not demonstrate significant differences in relation to tumor metastasis and patient mortality within a 3-year period (<xref rid="sup1" ref-type="supplementary-material">Fig. S1D and S1F</xref>). Given that caspase-3 and GSDME are two key factors involved in cell pyroptosis, we propose that caspase-3 may serve as a potential co-factor of GSDME in promoting pyroptosis in osteosarcoma cells. Therefore, GSDME can potentially serve as a risk assessment factor for investigating the onset of osteosarcoma, while caspase-3 can be utilized in conjunction for evaluation. Overall, these results indicate that &#x003b1;-MG tends to induce pyroptosis in osteosarcoma cells with high expression of GSDME.</p><p>Since &#x003b1;-MG has been previously known to inhibit IDH1-R132H (<xref rid="CIT0017" ref-type="bibr">Kim et al., 2015</xref>), we established U2OS cells overexpressing IDH1-R132H and subsequently assessed the impact of &#x003b1;-MG on cell pyroptosis by Annexin V-PI double staining. We observed that overexpression of IDH1-R132H in U2OS cells did not result in any significant changes in the pyroptotic phenotype induced by &#x003b1;-MG, compared to wild-type control U2OS cells (<xref rid="sup1" ref-type="supplementary-material">Fig. S1G and S1H</xref>). In addition, we also employed the classic IDH1-R132H inhibitor AGI-5198 to treat U2OS cells in the presence of &#x003b1;-MG. Our result revealed that AGI-5198 did not significantly impact the pyroptotic phenotype induced by &#x003b1;-MG in U2OS cells, as assessed by Annexin V-PI double staining (<xref rid="sup1" ref-type="supplementary-material">Fig. S1I and S1J</xref>). Therefore, we propose that IDH1-R132H may not be the primary contributor to &#x003b1;-MG-induced cell pyroptosis in U2OS cells.</p><p>To explore the biological target of &#x003b1;-MG, we synthesized a biotin-labelled &#x003b1;-MG (biotin-&#x003b1;-MG, <xref rid="sup1" ref-type="supplementary-material">Fig. S2A&#x02013;F</xref>) to discover potential binding proteins using HuProt proteome microarray, followed by incubation with Cy3-conjugated streptavidin (<xref rid="F1" ref-type="fig">Fig. 1I</xref>). As a result, a protein with the highest signal to noise ratio (SNR) was identified as reticulon-4 (RTN4) (<xref rid="F1" ref-type="fig">Fig. 1J</xref>). It is well known that RTN4 contains three major isoforms: RTN4A, RTN4B, and RTN4C, which are characterized by the critical regulator of ER curvature (<xref rid="CIT0008" ref-type="bibr">Collins, 2006</xref>; <xref rid="CIT0018" ref-type="bibr">Kiseleva et al., 2007</xref>; <xref rid="CIT0020" ref-type="bibr">Kumar et al., 2021</xref>). Here, we found that RTN4B is the predominant isoform of RTN4 expressed in various tumors, especially in sarcoma by the cancer genome atlas (TCGA) database analysis (<xref rid="sup1" ref-type="supplementary-material">Fig. S1K</xref>). Next, we found that biotin-&#x003b1;-MG predominantly captured RTN4B and a small amount of RTN4C, using competitive pull-down analysis (<xref rid="F1" ref-type="fig">Fig. 1K</xref>). Therefore, we focused on RTN4B for further investigation. The microscale thermophoresis (MST) assay demonstrated that both &#x003b1;-MG and biotin-&#x003b1;-MG directly bound to RTN4 (&#x003b1;-MG <italic toggle="yes">K</italic><sub>D</sub> = 12.1&#x02005;&#x000b1;&#x02005;1.28 nmol/L, biotin-&#x003b1;-MG <italic toggle="yes">K</italic><sub>D</sub> = 39.0&#x02005;&#x000b1;&#x02005;1.09 nmol/L) (<xref rid="F1" ref-type="fig">Figs. 1L</xref> and <xref rid="sup1" ref-type="supplementary-material">S2G</xref>). Furthermore, molecular docking analysis revealed that &#x003b1;-MG exhibited spatial bonding around RTN4 through the formation of multiple hydrogen bonds with residues such as glutamate (GLU) 34, GLU 37, and alanine 341 (<xref rid="F1" ref-type="fig">Fig. 1M</xref>). Similarly, biotin-&#x003b1;-MG is also bound to RTN4 through the establishment of several hydrogen bonds with GLU 34, GLU 37, and GLU 41 (<xref rid="sup1" ref-type="supplementary-material">Fig. S2H</xref>). Taken together, we identify RTN4 as a direct binding protein of &#x003b1;-MG that is highly associated with pyroptosis progression.</p></sec><sec id="s4"><title>RTN4 deficiency significantly promotes pyroptosis phenotype</title><p>To determine whether RTN4 plays a role in pyroptosis progression, we performed RTN4 silencing in osteosarcoma cell lines (U2OS, HOS, and 143B) and observed significant pyroptosis-associated &#x0201c;bubble&#x0201d; morphology by Annexin V-PI double staining (<xref rid="F2" ref-type="fig">Figs. 2A</xref> and <xref rid="sup1" ref-type="supplementary-material">S3A</xref>). Similar phenotypes were also observed in other cell lines such as HeLa and MGC803 (<xref rid="F2" ref-type="fig">Fig. 2A</xref>). Moreover, flow-cytometry analyses showed that RTN4 siRNA significantly elevated the pyroptosis percentage of Annexin V-PI positive cells (<xref rid="F2" ref-type="fig">Figs. 2B</xref> and <xref rid="sup1" ref-type="supplementary-material">S3B</xref>). We next constructed a lentiviral miR30-based Tet-inducible (pLKO-Tet-On) short hairpin RNA (shRNA) system to specially knock down RTN4 in U2OS cells (<xref rid="sup1" ref-type="supplementary-material">Fig. S3C and S3D</xref>). As shown in <xref rid="F2" ref-type="fig">Fig. 2C</xref>, doxycycline (dox) significantly induced typical pyroptotic &#x0201c;bubble&#x0201d; morphology in U2OS cells by Annexin V-PI double staining (<xref rid="F2" ref-type="fig">Fig. 2D</xref>). Also, dox treatment increased LDH release in U2OS cells (<xref rid="F2" ref-type="fig">Fig. 2E</xref>), suggesting that RTN4 deficiency highly contributes to pyroptosis progression.</p><fig position="float" id="F2"><label>Figure 2.</label><caption><p>RTN4 deficiency significantly promotes pyroptosis phenotype. (A) RTN4 siRNA induced obvious pyroptosis morphology in U2OS, HeLa, and MGC803 by Annexin V-PI double staining (scale bar: 25 &#x003bc;m). (B) RTN4 siRNA increased the ratio of pyroptotic cells by Annexin V-PI flow analysis. (C) Doxycycline (dox)-mediated RTN4 downregulation induced pyroptosis morphology in U2OS cells by Annexin V-PI double staining (scale bar: 25 &#x003bc;m). (D) Dox-mediated RTN4 downregulation increased the ratio of pyroptotic cells by Annexin V-PI flow analysis. (E) LDH release was significantly elevated after dox treatment. (F&#x02013;H) RTN4 siRNA treatment enhanced the pyroptosis phenotype in tumor necrosis factor-&#x003b1; (TNF&#x003b1;)/CHX or cisplatin (DDP)-treated U2OS cells by Annexin V-PI double staining (scale bar: 25 &#x003bc;m), quantitative flow and LDH release assay. (I, J, and K) Hypoxia and UV radiation showed synergetic effects with RTN4 siRNA on pyroptosis by Annexin V-PI double staining (scale bar: 25 &#x003bc;m), flow, and LDH release assay. (L) RTN4 expression was down-regulated in chemical or physical stress-treated U2OS cells. (M) RTN4 knockdown activated caspase-3 to cleave GSDME. (N) RAW264.7 cells exhibited a significant activation by the supernatants from U2OS cells with RTN4 knockdown. The expressions of TNF-&#x003b1;, interleukin-6 (IL-6), inducible nitric oxide synthase (iNOS), and IL-1&#x003b2; were determined by qPCR assay. Data were presented as mean&#x02005;&#x000b1;&#x02005;SD for three individual experiments. *<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;0.05, **<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;0.01 vs. control group.</p></caption><graphic xlink:href="pwae049_fig2" position="float"/></fig><p>Next, we explored the synergic effect of RTN4 knockdown with various cell stress stimulations. We observed that RTN4 knockdown sensitized the pyroptosis phenotype in TNF-&#x003b1;/cycloheximide (CHX) (<xref rid="CIT0012" ref-type="bibr">Hu et al., 2020</xref>) or cis-platinum (DDP) (<xref rid="CIT0037" ref-type="bibr">Wang et al., 2017</xref>) -treated U2OS cells (<xref rid="F2" ref-type="fig">Fig. 2F</xref>). Meanwhile, HeLa and MGC803 cells exhibited heightened susceptibility to pyroptosis following RTN4 knockdown (<xref rid="sup1" ref-type="supplementary-material">Fig. S3E</xref>). These observations were further confirmed by quantitative flow-cytometry measurement (<xref rid="F2" ref-type="fig">Fig. 2G</xref>) and LDH release assay (<xref rid="F2" ref-type="fig">Fig. 2H</xref>). Subsequently, physical stimulations such as hypoxia (<xref rid="CIT0043" ref-type="bibr">Yu et al., 2019</xref>) and UV radiation (<xref rid="CIT0026" ref-type="bibr">Liu et al., 2021</xref>) also showed synergetic effects on pyroptosis induction in the presence of RTN4 knockdown (<xref rid="F2" ref-type="fig">Figs. 2I&#x02013;K</xref> and <xref rid="sup1" ref-type="supplementary-material">S3F</xref>). Interestingly, both chemical and physical stress downregulated the expression of RTN4, which represented a universal biological response during pyroptosis (<xref rid="F2" ref-type="fig">Fig. 2L</xref>). Furthermore, immunoblot assay revealed that RTN4 deficiency dramatically activated caspase-3 to cleave GSDME (<xref rid="F2" ref-type="fig">Figs. 2M</xref> and <xref rid="sup1" ref-type="supplementary-material">S3G</xref>), and subsequently prompted a strong immune response in RAW264.7 macrophages by enhancing inflammatory gene expressions of TNF-&#x003b1;, IL-6, iNOS, and IL-1&#x003b2; (<xref rid="F2" ref-type="fig">Figs. 2N</xref> and <xref rid="sup1" ref-type="supplementary-material">S3H</xref>). Finally, we performed a rescue experiment in TetOn-RTN4 shRNA U2OS stable cell lines to elucidate the isoform of RTN4 involved in mediating pyroptosis. Remarkably, our results presented in <xref rid="sup1" ref-type="supplementary-material">Fig. S3I</xref> revealed that the overexpression of RTN4B effectively restored caspase-3 and GSDME cleavage, whereas the transfection of RTN4A or RTN4C plasmids did not induce a comparable effect. Collectively, these findings strongly suggest that RTN4B plays a pivotal role in the regulation of pyroptosis.</p></sec><sec id="s5"><title>&#x003b1;-MG serves as a RTN4 degrader by recruiting E3 ligase UBR5 in ubiquitin-proteasome system</title><p>Next, we examined the effect of &#x003b1;-MG on the expression of RTN4. Interestingly, we observed that &#x003b1;-MG significantly reduced RTN4 protein expression in a concentration- and time-dependent manner (<xref rid="F3" ref-type="fig">Figs. 3A</xref> and <xref rid="sup1" ref-type="supplementary-material">S4A</xref>), without affecting mRNA levels (<xref rid="sup1" ref-type="supplementary-material">Fig. S4B</xref>). Then, we used protein synthesis inhibitor cycloheximide (CHX) to block RTN4 protein synthesis and found that RTN4 expression was also downregulated upon &#x003b1;-MG treatment, suggesting that &#x003b1;-MG functions as a RTN4 chemical degrader (<xref rid="F3" ref-type="fig">Fig. 3B</xref>). Subsequent treatment with MG132 and Bafilomycin A1 (BafA1) indicated that &#x003b1;-MG predominantly degraded RTN4 through the proteasome system rather than the lysosomal pathway (<xref rid="F3" ref-type="fig">Fig. 3C</xref>).</p><fig position="float" id="F3"><label>Figure 3.</label><caption><p>
<bold>&#x003b1;</bold>-MG serves as a RTN4 degrader by recruiting E3 ligase UBR5 in ubiquitin-proteasome system. (A) &#x003b1;-MG downregulated RTN4 expression in a concentration- and time-dependent manner by immunoblot assay. (B) &#x003b1;-MG downregulated RTN4 expression in the presence of CHX at different time points. (C) Proteasome inhibitor MG132 but not lysosome inhibitor Bafilomycin A1 reversed &#x003b1;-MG-induced RTN4 degradation by western blot. (D) &#x003b1;-MG promoted the K48-linked but not the K63-linked ubiquitination of RTN4. (E) Transfection of K48-resistant ubiquitin (Lys48 to Arg48 mutant, K48R) reversed the ubiquitination of RTN4. (F) Co-IP coupled with MS identified RTN4-interacting protein components. The table showed representative ubiquitin-protein ligases identified by MS. (G) The impact of E3 ligase knockdown on RTN4 degradation in response to &#x003b1;-MG treatment. (H and I) The influence of UBR5 on pyroptosis in U2OS cells was characterized by Annexin V-PI double staining (scale bar: 25 &#x003bc;m). **<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;0.01 vs. control group.</p></caption><graphic xlink:href="pwae049_fig3" position="float"/></fig><p>Given that the degradation of RTN4 primarily relies on the proteasomal pathway, we next investigated whether RTN4 undergoes ubiquitination modification. Western blot analysis revealed that &#x003b1;-MG significantly promoted the ubiquitination modification of RTN4 (<xref rid="F3" ref-type="fig">Fig. 3D</xref>). In particular, this ubiquitination modification was mainly mediated by K48-dependent ubiquitin chain formation, with little impact on K63 ubiquitin chain formation (<xref rid="F3" ref-type="fig">Fig. 3E</xref>). We then hypothesized that &#x003b1;-MG facilitated K48-dependent ubiquitination modification of RTN4 by recruiting specific E3 ligases. Therefore, we immunoprecipitated HA-tagged RTN4 after MG132 treatment and identified the interacting proteins using mass spectrometry (MS) (<xref rid="F3" ref-type="fig">Fig. 3F</xref>). Then, we identified a total of 1,290 intracellular proteins that interact with RTN4. Upon refining the key ubiquitin ligases of RTN4, we finally identified six E3 ligases, including TRIM21, UBR5, TRIM28, TRAF7, CHIP, and TRIP12 (<xref rid="F3" ref-type="fig">Fig. 3F</xref>). Meanwhile, we also identified the E1 ubiquitin-activating enzyme UBA1 and the E2 ubiquitin enzyme UBE2D3 (<xref rid="F3" ref-type="fig">Fig. 3F</xref>). To further determine which E3 ubiquitin ligase is involved in the ubiquitination of RTN4, we knocked down the expression of these E3 ubiquitin ligases in cells using siRNA. Then, we treated the cells with &#x003b1;-MG and found that the degradation of RTN4 induced by &#x003b1;-MG was only reversed upon UBR5 knockdown (<xref rid="F3" ref-type="fig">Fig. 3G</xref>). Moreover, UBR5 knockdown effectively hindered &#x003b1;-MG-induced pyroptotic bodies formation (<xref rid="sup1" ref-type="supplementary-material">Fig. S4C</xref>). Additionally, we observed that overexpression of UBR5 induced a &#x0201c;bubble&#x0201d; morphology in U2OS cells, as assessed by Annexin V-PI double staining and quantified via flow-cytometry analysis (<xref rid="F3" ref-type="fig">Fig. 3H</xref> and <xref rid="F3" ref-type="fig">3I</xref>). Thus, we concluded that &#x003b1;-MG likely promoted the molecular glue-like interaction between UBR5 and RTN4, subsequently enhancing the downstream proteasomal degradation of RTN4 via the K48-dependent pathway.</p></sec><sec id="s6"><title>RTN4 knockdown remodels ER membrane curvature via tubule-to-sheet change</title><p>Since RTN4 functions as a pivotal protein in regulating ER membrane curvature, thus RTN4 deficiency is likely to impact the morphological characteristics of ER (<xref rid="CIT0020" ref-type="bibr">Kumar et al., 2021</xref>). Here, confocal fluorescence analysis revealed that RTN4 knockdown by siRNA induced ER morphology alteration from grid-like tubules to flattened sheet-like structures in U2OS cells, which were transfected with ER markers Sec61&#x003b2;-EGFP and Lys-Asp-Glu-Leu (KDEL)-pDsRed2 (<xref rid="F4" ref-type="fig">Fig. 4A</xref>). Moreover, we observed that chemical-induced RTN4 degradation with &#x003b1;-MG also markedly triggered ER tubules-to-sheets transition (<xref rid="F4" ref-type="fig">Fig. 4B</xref>). Furthermore, we performed transmission electron microscope (TEM) analysis to confirm the marked increases in the proportion of sheet ER over 10 &#x003bc;m in length both in RTN4 siRNA and &#x003b1;-MG-treated U2OS cells (<xref rid="F4" ref-type="fig">Fig. 4C</xref> and <xref rid="F4" ref-type="fig">4D</xref>). Since atlastin-1 serves as a critical mediator of tubular ER formation, we also performed quantitative real-time PCR (qPCR) analysis and found that the mRNA expression of atlastin-1 was significantly downregulated in RTN4-silenced U2OS cells, as well as HeLa and MGC803 (<xref rid="F4" ref-type="fig">Fig. 4E</xref>), indicating that ER tubules-to-sheets transition was highly associated with the intracellular expression of RTN4.</p><fig position="float" id="F4"><label>Figure 4.</label><caption><p>RTN4 knockdown remodels ER membrane curvature via tubule-to-sheet change. (A and B) RTN4 knockdown or &#x003b1;-MG-induced obvious ER tubules-to-sheets morphology in U2OS cells expressing Sec61&#x003b2;-EGFP and KDEL-pDsRed2 by Airyscan super-resolution microscopy (scale bar: 10 &#x003bc;m). (C and D) TEM imaging of tubular ER (less 10 &#x003bc;m in length) and sheet ER (over 10 &#x003bc;m in length) in RTN4 siRNA or &#x003b1;-MG-treated U2OS cells (scale bar: 10 &#x003bc;m). (E) Atlastin-1 mRNA expression was downregulated in RTN4-silenced U2OS, HeLa, and MGC803 cells by qPCR analysis. (F) ER stress inhibitors TUDCA or 4-PBA reversed RTN4 knockdown-induced pyroptosis morphology; meanwhile, ER stress inducers TG or TM enhanced the &#x0201c;bubble&#x0201d; morphology in U2OS cells by Annexin V-PI double staining (scale bar: 25 &#x003bc;m). (G) Quantitative analysis of Annexin V-PI double positive pyroptotic cells by flow cytometry. (H) LDH release analysis of ER stress inhibitors or inducers-treated U2OS cells upon RTN4 knockdown. (I) RTN4-interacting proteins were enriched via Co-IP assay in U2OS cells and classified into 5 function-based groups. (J) RTN4 interacted with PKM2 by co-IP assay from the lysates of HA-RTN4 overexpressed-U2OS cells. (K) &#x003b1;-MG exhibited a concentration-dependent decrease in PKM2 protein expression. (L) The dissociation constant (<italic toggle="yes">K</italic><sub>D</sub>) between RTN4 with PKM2 was measured as 151.12&#x02005;&#x000b1;&#x02005;16.84 nmol/L by MST. (M, N, and O) Annexin V-PI double staining (scale bar: 25 &#x003bc;m), quantitative flow and LDH release assay confirmed that PKM2 knockdown triggered pyroptosis phenotype in U2OS cells. (P) PKM2 knockdown triggered caspase-3/GSDME pathway. (Q) Schematic of the RTN4-mediated pyroptosis mechanism. RTN4 degradation results in the release of its interacting protein, PKM2, which triggers the activation of the PKM2-mediated caspase-3/GSDME signaling pathway. Data were presented as mean&#x02005;&#x000b1;&#x02005;standard deviation (SD) for three individual experiments. *<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;0.05, **<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;0.01 vs. control group.</p></caption><graphic xlink:href="pwae049_fig4" position="float"/></fig><p>Recent evidence indicates that RTN4 morphological imbalance potentially induces ER stress (<xref rid="CIT0019" ref-type="bibr">Kuang et al., 2006</xref>; <xref rid="CIT0030" ref-type="bibr">Oertle et al., 2003</xref>). We then performed Annexin V-PI double staining and observed that ER stress inhibitors tauroursodeoxycholic acid (TUDCA) or 4-phenylbutiric acid (4-PBA) reversed RTN4 knockdown-induced &#x0201c;bubble&#x0201d;-like pyroptosis phenotype (<xref rid="F4" ref-type="fig">Fig. 4F</xref>). Meanwhile, ER stress inducers thapsigargin (TG) or tunicamycin (TM) significantly enhanced the &#x0201c;bubble&#x0201d; morphology in U2OS cells (<xref rid="F4" ref-type="fig">Fig. 4F</xref>). These findings were also confirmed by flow cytometry (<xref rid="F4" ref-type="fig">Fig. 4G</xref>) and LDH release assay (<xref rid="F4" ref-type="fig">Fig. 4H</xref>), indicating a critical bridging function of ER stress in RTN4 deficiency-induced pyroptosis. Next, to gain a detailed insight into the relationship between RTN4 and ER morphology transition, we performed co-immunoprecipitation (co-IP) experiment to capture the RTN4-binding proteins in cells. Then, 96 proteins were significantly enriched, and classified into five classes, including cytoskeleton dynamics, membrane fluidity, transcription factor, ER stress, and others (<xref rid="F4" ref-type="fig">Fig. 4I</xref>). Among these RTN4-binding proteins, the pyruvate kinase M2 (PKM2) especially attracted our interest. Since PKM2 has previously been reported to be highly associated with pyroptosis progress via regulating ER stress (<xref rid="CIT0023" ref-type="bibr">Li et al., 2021a</xref>, <xref rid="CIT0024" ref-type="bibr">2021b</xref>), and thus considered as a crucial candidate protein for further investigation. To test the interaction of RTN4 with PKM2, we performed co-IP assay and found that RTN4 is directly bound to PKM2 (<xref rid="F4" ref-type="fig">Fig. 4J</xref>). In parallel, the treatment of &#x003b1;-MG led to a downregulation of PKM2 expression, ultimately resulting in the cleavage of GSDME (<xref rid="F4" ref-type="fig">Fig. 4K</xref>). Furthermore, MST analysis to quantificationally characterize the affinity of RTN4 with PKM2 revealed the dissociation constant (<italic toggle="yes">K</italic><sub>D</sub>) as 151.12&#x02005;&#x000b1;&#x02005;16.84 nmol/L (<xref rid="F4" ref-type="fig">Fig. 4L</xref>), demonstrating a potent interaction between RTN4 and PKM2. Furthermore, PKM2 knockdown prompted &#x0201c;bubble&#x0201d; morphology in U2OS cells that was characterized by Annexin V-PI double staining (<xref rid="F4" ref-type="fig">Fig. 4M</xref> and <xref rid="F4" ref-type="fig">4N</xref>). Meanwhile, PKM2 knockdown facilitated LDH release, eventually triggering pyroptosis by inducing caspase-3/GSDME activation (<xref rid="F4" ref-type="fig">Fig. 4O&#x02013;Q</xref>). Next, to investigate the influence of PKM2 on ER membrane curvature, we conducted confocal fluorescence analysis in U2OS cells expressing the ER marker Sec61&#x003b2;-EGFP. PKM2 knockdown failed to induce ER tubules-to-sheets transition (<xref rid="sup1" ref-type="supplementary-material">Fig. S5A</xref>). Furthermore, we observed UBR5 overexpression-induced ER morphology alteration from grid-like tubules to flattened sheet-like structures (<xref rid="sup1" ref-type="supplementary-material">Fig. S5B</xref>). Meanwhile, knockdown of UBR5 by siRNA had no obvious effect on ER membrane curvature alteration (<xref rid="sup1" ref-type="supplementary-material">Fig. S5C</xref>). Thus, these findings suggest that UBR5 but not PKM2 is an upstream signaling pathway regulating ER membrane curvature remodeling.</p><p>Finally, we conducted experiments to delve deeper into the correlation between ER membrane curvature remodeling and caspase-3/GSDME signaling. Our results revealed that the inhibition of caspase-3 using Z-DEVD-FMK or the depletion of GSDME through siRNA did not produce any noticeable impacts on the curvature of ER membrane such as the &#x0201c;tubule-to-sheet&#x0201d; transition (<xref rid="sup1" ref-type="supplementary-material">Fig. S5D and S5E</xref>). These findings suggest that caspase-3/GSDME signaling may potentially be situated downstream of ER membrane curvature remodeling.</p><p>In summary, our findings suggest that RTN4 deficiency-induced ER membrane curvature change results in pyroptosis via ER stress signaling pathway.</p></sec><sec id="s7"><title>Membrane curvature change drives ER fusion to the &#x0201c;bubble&#x0201d; structures during pyroptosis</title><p>The &#x0201c;bubble&#x0201d; structure formation is a crucial biological event in pyroptosis (<xref rid="CIT0005" ref-type="bibr">Chen et al., 2016</xref>). To explore the role of ER in RTN4 deficiency-induced &#x0201c;bubble&#x0201d;-like phenotype, we applied a series of fluorescent probes for cell organelles staining (ER tracker, Mito tracker, Lyso tracker, Golgi tracker, and Cell membrane tracker DiI). Interestingly, we found that RTN4-knockdown-induced &#x0201c;bubble&#x0201d; structures were obviously labelled by ER tracker, but not Mito tracker or Lyso tracker; while the bubbles were mildly labelled by Golgi tracker and DiI (<xref rid="F5" ref-type="fig">Fig. 5A</xref>). Accordingly, we also confirmed this finding by RTN4 degrader &#x003b1;-MG (<xref rid="sup1" ref-type="supplementary-material">Fig. S6A</xref>). &#x003b1;-MG treatment resulted in the presence of ER in the &#x0201c;bubble&#x0201d; structures by TEM imaging (<xref rid="F5" ref-type="fig">Fig. 5B</xref>). Next, to confirm the direct connection between ER and the &#x0201c;bubble&#x0201d; structures, we overexpressed ER markers (Sec61&#x003b2;, Calnexin, KDEL) in U2OS cells. Living cell imaging analysis showed that upon RTN4 knockdown with siRNA, the green fluorescence from Sec61&#x003b2;-EGFP appeared in the &#x0201c;bubble&#x0201d; structures (<xref rid="F5" ref-type="fig">Fig. 5C</xref>). Similar results were also confirmed in dox-inducible RTN4 knockdown model (<xref rid="F5" ref-type="fig">Fig. 5D</xref>). Moreover, Calnexin-EGFP-labelled ER membrane and pDsRed2-KDEL-labelled ER lumen were also highly expressed in the &#x0201c;bubble&#x0201d; structures of RTN4 knockdown cells (<xref rid="F5" ref-type="fig">Fig. 5E</xref> and <xref rid="F5" ref-type="fig">5F</xref>). RTN4 degrader &#x003b1;-MG phenocopied the genetic RTN4 knockdown in the translocation of these ER markers to the &#x0201c;bubble&#x0201d; structures by fluorescence confocal (<xref rid="sup1" ref-type="supplementary-material">Fig. S6B and S6C</xref>). Furthermore, RTN4 silencing markedly prompted Sec61&#x003b2;-EGFP-labelled ER membrane co-location with GSDME-N pores around the &#x0201c;bubble&#x0201d; structures (<xref rid="sup1" ref-type="supplementary-material">Fig. S6D</xref>). Meanwhile, RTN4 degrader &#x003b1;-MG exhibited a similar effect to induce Sec61&#x003b2;-labelled ER membrane translocation (<xref rid="sup1" ref-type="supplementary-material">Fig. S6E</xref>).</p><fig position="float" id="F5"><label>Figure 5.</label><caption><p>RTN4 knockdown promotes ER-membrane fusion to the &#x0201c;bubble&#x0201d; structures. (A) Fluorescence probes (ER tracker, Mito tracker, Lyso tracker, Golgi tracker, and Cell membrane tracker DiI) tracking of the &#x0201c;bubble&#x0201d; structures (scale bar: 25 &#x003bc;m). (B) &#x003b1;-MG-induced ER translocation onto the &#x0201c;bubble&#x0201d; structures as shown by TEM imaging (scale bar: 10 &#x003bc;m). (C and D) Sec61&#x003b2;-EGFP-labelled ER membrane translocated onto the &#x0201c;bubble&#x0201d; structures in RTN4 siRNA-treated U2OS cells or dox-inducible RTN4 knockdown model, which was enhanced by TNF&#x003b1;/CHX or DDP. (E and F) Calnexin-EGFP-labelled ER membrane or pDsRed2-KDEL-labelled ER lumen translocated to the &#x0201c;bubble&#x0201d; structures in RTN4 siRNA-treated U2OS cells, which was enhanced by TNF&#x003b1;/CHX or DDP. (G) ER marker proteins like Sec61&#x003b2;, Calnexin, and KEDL were secreted to supernatants upon RTN4 downregulation by immunoblot assay. (H) Schematic representation of the liposome-binding assay. Purified ER proteins were incubated with liposomes with 80% phosphatidylcholine and 20% cardiolipin. After ultracentrifugation, the liposome-free supernatants and the liposome pellets were analyzed by SDS-PAGE and Coomassie staining. (I) Liposomes preferred to bind with sheet ER rather than tubular ER. S: supernatants; P: pellets. (J) ER membrane proteins (Sec61&#x003b2; and Calnexin) were highly expressed at liposome-binding sheet ER constituents by immunoblot assay.</p></caption><graphic xlink:href="pwae049_fig5" position="float"/></fig><p>In addition, immunoblot assay showed that ER proteins (Sec61&#x003b2;, Calnexin, and KDEL) were released from cytosol to culture supernatants in response to RTN4 knockdown (<xref rid="F5" ref-type="fig">Fig. 5G</xref>), further supporting our assumption that ER may translocate to the &#x0201c;bubble&#x0201d; structures during pyroptosis. Of note, liposome-binding assay demonstrated that the proteins from purified sheet ER rather than tubular ER showed a binding preference for liposomes that resembled intracellular membranes (<xref rid="F5" ref-type="fig">Figs. 5H</xref>, <xref rid="F5" ref-type="fig">5I</xref> and <xref rid="sup1" ref-type="supplementary-material">S6F</xref>). Moreover, ER membrane proteins including Sec61&#x003b2; and Calnexin were mostly found in pellets composed of sheet ER constituents binding with liposomes (<xref rid="F5" ref-type="fig">Fig. 5J</xref>). Taken together, these data demonstrate that ER is highly involved in pyroptosis progression by promoting its membrane fusion to the &#x0201c;bubble&#x0201d; structures during pyroptosis.</p></sec><sec id="s8"><title>Plasma membrane disturbance synergistically promotes RTN4 deficiency-induced pyroptosis</title><p>Since ER membrane may contribute to constructing the &#x0201c;bubble&#x0201d; structures by ER-plasma membrane fusion, we then speculated that plasma membrane disturbance may affect pyroptosis progress. To this end, we used amphiphilic surfactant Triton X-100 to mildly treat the cells for partly removing Triton X-100-soluble plasma membrane constituents (<xref rid="CIT0001" ref-type="bibr">Adachi et al., 2007</xref>). As shown in <xref rid="F6" ref-type="fig">Fig. 6A</xref>, Triton X-100 alone did not trigger obvious pyroptosis in U2OS cells; however, Triton X-100 greatly upregulated the proportion of dox-induced &#x0201c;bubble&#x0201d; structures by Annexin V-PI double staining and flow analysis (<xref rid="F6" ref-type="fig">Fig. 6B</xref>). Moreover, Triton X-100 also significantly promoted the LDH release in dox-induced U2OS cells (<xref rid="F6" ref-type="fig">Fig. 6C</xref>). Similarly, Triton X-100 accelerated the &#x0201c;bubble&#x0201d; structures formation in RTN4 degrader &#x003b1;-MG-induced U2OS cells (<xref rid="F6" ref-type="fig">Fig. 6D&#x02013;F</xref>). Furthermore, overexpression of GSDME-N enhanced &#x003b1;-MG-induced &#x0201c;bubble&#x0201d; structures formation in pyroptosis (<xref rid="F6" ref-type="fig">Fig. 6G</xref> and <xref rid="F6" ref-type="fig">6H</xref>). Collectively, these results indicate that plasma membrane homeostasis plays an essential role in promoting the &#x0201c;bubble&#x0201d; structures formation during RTN4 knockdown-induced pyroptosis.</p><fig position="float" id="F6"><label>Figure 6.</label><caption><p>Plasma membrane disturbance synergistically promotes RTN4 deficiency-induced pyroptosis. (A and B) Triton X-100 (0.01%) upregulated the proportion of dox-induced &#x0201c;bubble&#x0201d; structures by Annexin V-PI double staining (scale bar: 25 &#x003bc;m) and flow analysis. (C) Triton X-100 significantly promoted the LDH release in dox-induced U2OS cells. (D) Triton X-100 synergistically promoted the &#x0201c;bubble&#x0201d; structures formation in &#x003b1;-MG-induced U2OS cells by Annexin V-PI double staining (scale bar: 25 &#x003bc;m). (E and F) Triton X-100 synergistically promoted pyroptosis in U2OS cells by flow analysis and LDH release assay. (G) GSDME-N overexpression with a mCherry tag enhanced &#x003b1;-MG-induced &#x0201c;bubble&#x0201d; structures formation (scale bar: 25 &#x003bc;m). (H) GSDME-N overexpression upregulated &#x003b1;-MG-induced proportion of pyroptotic cells. Data were presented as mean&#x02005;&#x000b1;&#x02005;SD for three individual experiments. **<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;0.01 vs. control group.</p></caption><graphic xlink:href="pwae049_fig6" position="float"/></fig></sec><sec id="s9"><title>Translational study of RTN4 degrader for anticancer therapy</title><p>To evaluate the antitumor potential of RTN4-targeting strategy, we established a 3D tumor spheroids model stained by Calcein-AM and EthD-1 (<xref rid="CIT0014" ref-type="bibr">Kamoshima et al., 2011</xref>). As shown in <xref rid="F7" ref-type="fig">Fig. 7A</xref>, dox exhibited a concentration-dependent antitumor activity in inhibiting the growth of 3D tumor models. RTN4 degrader &#x003b1;-MG also showed a similar result (<xref rid="F7" ref-type="fig">Fig. 7A</xref>). Next, we established an osteosarcoma xenograft mouse model using the K7M2 cells expressing RTN4 shRNA activated by dox. We found that intratumor injection of dox efficiently impaired tumorigenesis via downregulation of RTN4 expression (<xref rid="F7" ref-type="fig">Figs. 7B</xref>, <xref rid="F7" ref-type="fig">7C</xref>, <xref rid="sup1" ref-type="supplementary-material">S7A and S7B</xref>). Next, to explore the clinical transformation feasibility of RTN4 degradation for anticancer therapy, we tested the therapeutic effect of the oral administration of RTN4 degrader &#x003b1;-MG on K7M2-bearing mice. We observed that &#x003b1;-MG (50 or 100 mg/kg) significantly decreased the sizes (<xref rid="sup1" ref-type="supplementary-material">Fig. S7C and S7D</xref>) and weights (<xref rid="sup1" ref-type="supplementary-material">Fig. S7E</xref>) of K7M2 tumors, without body weight reduction (<xref rid="sup1" ref-type="supplementary-material">Fig. S7F</xref>). Moreover, immunohistochemistry (IHC) analysis showed that &#x003b1;-MG strongly upregulated T cell marker CD8, NK cell marker CD56, as well as macrophages marker F4/80 levels in tumor tissues (<xref rid="sup1" ref-type="supplementary-material">Fig. S7G</xref>), indicating an obvious effect of activating antitumor immunity. Meanwhile, we found that programmed cell death 1 ligand 1 (PD-L1) expression was significantly upregulated upon &#x003b1;-MG treatment (<xref rid="sup1" ref-type="supplementary-material">Fig. S7G</xref>), suggesting a synergistic possibility of &#x003b1;-MG with immune checkpoint therapy. We then designed a combination scheme with &#x003b1;-MG and anti-PD-1 antibody (<xref rid="F7" ref-type="fig">Fig. 7D</xref>). Our result showed that &#x003b1;-MG administration coupled with anti-PD-1 treatment displayed a marked synergistic action in reducing tumor volumes and weights (<xref rid="F7" ref-type="fig">Figs. 7E</xref>, <xref rid="F7" ref-type="fig">7F</xref> and <xref rid="sup1" ref-type="supplementary-material">S7H</xref>), without obvious adverse effects on body weights, organ weights, and serum biochemical indicators (<xref rid="sup1" ref-type="supplementary-material">Fig. S7I&#x02013;L</xref>).</p><fig position="float" id="F7"><label>Figure 7.</label><caption><p>Translational study of RTN4 degrader for anticancer therapy. (A) 3D U2OS tumor spheroids were stained by Calcein-AM and EthD-1 at different concentrations of Dox (0.5, 1, and 2 &#x003bc;g/mL) for 24 h. RTN4 degrader &#x003b1;-MG (40 &#x003bc;mol/L) was also added for 3 h to induce tumor spheroid disintegration. Scale bar: 100 &#x003bc;m. (B and C) Intratumor injection of dox into the K7M2 osteosarcoma xenograft model containing a dox-inducible RTN4 shRNA lentivirus vector retarded tumor growth and downregulated the tumor weights. (D) Procedure of a combination scheme with &#x003b1;-MG and anti-PD-1 antibody. (E and F) &#x003b1;-MG administration coupled with anti-PD1 treatment displayed a marked synergistic action in reducing tumor growth and weights. (G) Detection of RTN4 expression on osteosarcoma chip containing 101 clinical samples. Scale bar: 200 &#x003bc;m. (H) Immunohistochemical staining scoring of RTN4 expression based on whether the tumors metastasized and the patients died within 3 years. Data were presented as mean&#x02005;&#x000b1;&#x02005;SD (<italic toggle="yes">n</italic>&#x02005;=&#x02005;6). *<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;0.05, **<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;0.01 vs. control group. (I) Virtual screening of RTN4-targeting small molecules. (J) Mitoxantrone, crizotinib, and idarubicin concentration-dependently increased the proportion of pyroptosis by Annexin V-PI double staining (scale bar: 25 &#x003bc;m).</p></caption><graphic xlink:href="pwae049_fig7" position="float"/></fig><p>Furthermore, we detected RTN4 expression in paraffin-embedded specimens gathered from 101 patients with primary osteosarcoma by immunohistochemistry. The results revealed that high levels of RTN4 in osteosarcoma tissues as characterized by strong staining were positively associated with tumor metastasis and death of patients within 3 years via the manual scoring method (<xref rid="F7" ref-type="fig">Figs. 7G</xref>, <xref rid="F7" ref-type="fig">7H</xref> and <xref rid="sup1" ref-type="supplementary-material">S8</xref>). In addition, we evaluated the immunohistochemical features of RTN4 in osteosarcoma tissues and normal bone tissues, which indicated a relatively high expression of RTN4 present in osteosarcoma tissues (<xref rid="sup1" ref-type="supplementary-material">Fig. S7M</xref>). Therefore, these results indicate that RTN4 may represent an available biomarker or therapeutic target for anticancer in translational medicine research.</p><p>Given the functional significance of RTN4 in pyroptosis as well as osteosarcoma progression, the inhibition of RTN4 represents a potential strategy for tumor therapy. To this end, we conducted a high-throughput virtual screening using the DrugBank Database, which comprises 10,845 compounds. Each compound was docked into the predicted binding pocket of the RTN4 structure generated by I-TASSER. Subsequently, Glide XP GScore values (kcal/mol), representing the binding affinities of these compounds to RTN4, were calculated. From this screening, the top 20 compounds (<xref rid="F7" ref-type="fig">Fig. 7I</xref>) were selected for further experimental validation. Using the MST assay, we confirmed that a majority of these compounds exhibited strong binding affinity to RTN4 (<xref rid="sup1" ref-type="supplementary-material">Fig. S7N</xref>). Additionally, the characteristic analysis of pyroptosis in U2OS cells under bright-field microscopy as well as Annexin V-PI double staining revealed that Mitoxantrone, Crizotinib, and Idarubicin markedly induced pyroptosis (<xref rid="sup1" ref-type="supplementary-material">Figs. S7O, S7P</xref> and <xref rid="sup1" ref-type="supplementary-material">7J</xref>). Taken together, we have demonstrated the potential of targeting RTN4 to induce pyroptosis, thereby providing lead compounds for the development of RTN4-targeted therapeutic agents.</p></sec></sec><sec id="s10"><title>Discussion</title><p>Accumulating studies have shown that pyroptosis, a newly discovered programmed cell death, undergoes a unique biological membrane reconstruction process to produce &#x0201c;bubble&#x0201d; structures (<xref rid="CIT0032" ref-type="bibr">R&#x000fc;hl et al., 2018</xref>; <xref rid="CIT0039" ref-type="bibr">Wang et al., 2021</xref>). During this process, ER has been reported to function as a potential driving force to promote pyroptosis progression (<xref rid="CIT0035" ref-type="bibr">Tall and Westerterp, 2019</xref>), however, the detailed biological mechanisms are still missing. In this study, we discovered that ER-shaping protein RTN4 exerted a fundamental function in promoting the &#x0201c;bubble&#x0201d; structures formation during pyroptosis. Moreover, chemical or genetic knockdown of RTN4 significantly induced ER tubules-to-sheets change to accelerate ER stress and subsequent GSDME cleavage. More importantly, RTN4 knockdown regulated ER membrane curvature to promote contact and fusion with the plasma membrane, thereby potentially providing basic materials for building the &#x0201c;bubble&#x0201d; structures during pyroptosis.</p><p>As an important organelle in eukaryotic cells, ER is a continuous membrane system that forms the interconnected network of tubules and sheets (<xref rid="CIT0033" ref-type="bibr">Shibata et al., 2006</xref>). Here, our results provide an assumption that ER tubules-to-sheets change facilitates ER movement along microtubule cytoskeleton to GSDME membrane pores, hinting an interesting clue that ER provides raw biological materials for the &#x0201c;bubble&#x0201d; structures formation during pyroptosis. Given the pyroptotic cells generally produce the &#x0201c;bubble&#x0201d; structures within a short time (e.g., within 2 h), a feasible strategy for driving this progress is the efficient utilization of existing resources of ER membrane system, which serves as the largest continuous membrane-bound compartment in eukaryotic cells (<xref rid="CIT0032" ref-type="bibr">R&#x000fc;hl et al., 2018</xref>). Thus, we propose that cells may have evolved a potential ability to restructure biological membrane structure via reutilizing ER membrane materials (biology membrane economy). Although more measurements are needed to promote the confirmation of this hypothesis, our current findings may provide initial evidence to broaden our understanding of the function complexity and fast-response mechanism in pyroptosis progress.</p><p>As for the molecular mechanism how ER membrane dynamics mediates the &#x0201c;bubble&#x0201d; structures formation, one possible explanation for the initial stage may be that ER membranes fuse into plasma membrane, and are extruded out of gasdermin pores under osmotic pressure to form bubble-like structures (pre-pyroptotic bodies) (<xref rid="CIT0029" ref-type="bibr">Mamun et al., 2024</xref>; <xref rid="CIT0047" ref-type="bibr">Zheng et al., 2024</xref>). In fact, our observations support this speculation that several ER membrane proteins were identified on the pyroptotic bubbles including Sec61&#x003b2;, Calnexin, and KDEL. Moreover, we found that a small amount of Golgi markers was also expressed on the bubbles, suggesting that Golgi apparatus may be partly involved in the progress of plasm membrane blebbing via ER-Golgi trafficking. Moreover, another explanation may underline the importance of RTN4/PKM2 signaling in activating the cleavage of caspase 3 and GSDME, thereby contributing to a driving force in triggering pyroptosis punching.</p><p>Pyroptosis plays a pivotal role in reshaping the tumor immune microenvironment, thereby triggering robust antitumor immune responses. The specific benefit of RTN4-mediated pyroptosis in enhancing the efficacy of antitumor immune therapy lies in its capacity to increase the expression of PD-L1 in tumor cells and subsequently induce immune-mediated tumor cell death. The dual mechanism of attracting PD-L1-expressing tumor cells followed by selective elimination significantly enhances the therapeutic outcomes in tumor therapy. Currently, a major challenge for anticancer therapy via targeting pyroptosis suffers from a serious lack of available small molecules (<xref rid="CIT0028" ref-type="bibr">Loveless et al., 2021</xref>; <xref rid="CIT0037" ref-type="bibr">Wang et al., 2017</xref>). With &#x003b1;-MG as a specific RTN4 chemical degrader, we found that &#x003b1;-MG obviously decreased RTN4 expression for promoting ER tubules-to-sheets transition, subsequently causing pyroptosis in cancer cells. This observation further supported that RTN4 may function as a valuable drug target for anticancer by controlling ER dynamics in pyroptosis, indicating potential benefits in medical translation. Meanwhile, to the best of our knowledge, &#x003b1;-MG is the first small molecule targeting RTN4 to enhance pyroptosis-based antitumor immune responses. Specifically, &#x003b1;-MG may serve as a molecular glue to induce the RTN4 degradation by recruiting E3 ligase UBR5. Therefore, &#x003b1;-MG may provide a novel molecular templet for drug candidate development for anticancer via activating the function of ubiquitin-proteasome system.</p><p>In summary, we show that RTN4 is highly involved in driving pyroptosis via dynamic remodeling ER membrane curvature. These findings may provide an attractive direction for our understanding of the fundamental ER biology during pyroptosis, and underline the importance of RTN4 as a valuable anticancer target.</p></sec><sec id="s11" sec-type="supplementary-material"><title>Supplementary data</title><p>Supplementary data is available at <italic toggle="yes">Protein &#x00026; Cell</italic> online at <ext-link xlink:href="https://doi.org/10.1093/procel/pwae049" ext-link-type="uri">https://doi.org/10.1093/procel/pwae049</ext-link>.</p><supplementary-material id="sup1" position="float" content-type="local-data"><label>pwae049_suppl_Supplementary_Figures_S1-S8</label><media xlink:href="pwae049_suppl_supplementary_figures_s1-s8.pdf"/></supplementary-material></sec></body><back><glossary><def-list><title>Abbreviations</title><def-item><term>4-PBA</term><def><p>4-phenylbutiric acid</p></def></def-item><def-item><term>&#x003b1;-MG</term><def><p>&#x003b1;-mangostin</p></def></def-item><def-item><term>ALA</term><def><p>alanine</p></def></def-item><def-item><term>BafA1</term><def><p>Bafilomycin A1</p></def></def-item><def-item><term>co-IP</term><def><p>co-immunoprecipitation</p></def></def-item><def-item><term>dox</term><def><p>doxycycline</p></def></def-item><def-item><term>CHX</term><def><p>cycloheximide</p></def></def-item><def-item><term>ER</term><def><p>endoplasmic reticulum</p></def></def-item><def-item><term>GLU</term><def><p>glutamate</p></def></def-item><def-item><term>IHC</term><def><p>immunohistochemistry</p></def></def-item><def-item><term>LDH</term><def><p>lactate dehydrogenase</p></def></def-item><def-item><term>Lyso</term><def><p>lysosome</p></def></def-item><def-item><term>Mito</term><def><p>mitochondria</p></def></def-item><def-item><term>MST</term><def><p>microscale thermophoresis;</p></def></def-item><def-item><term>PKM2</term><def><p>pyruvate kinase M2</p></def></def-item><def-item><term>qPCR</term><def><p>quantitative polymerase chain reaction;</p></def></def-item><def-item><term>RTN4</term><def><p>reticulon-4</p></def></def-item><def-item><term>SARC</term><def><p>sarcoma</p></def></def-item><def-item><term>SD</term><def><p>standard deviation</p></def></def-item><def-item><term>shRNA</term><def><p>short hairpin RNA</p></def></def-item><def-item><term>siRNA</term><def><p>small interfering RNA</p></def></def-item><def-item><term>SNR</term><def><p>signal to noise ratio</p></def></def-item><def-item><term>TG</term><def><p>thapsigargin</p></def></def-item><def-item><term>TM</term><def><p>tunicamycin</p></def></def-item><def-item><term>TNF-&#x003b1;</term><def><p>tumor necrosis factor-&#x003b1;</p></def></def-item><def-item><term>TUDCA</term><def><p>tauroursodeoxycholic acid</p></def></def-item></def-list></glossary><sec id="s12"><title>Author contributions</title><p>K.-W.Z. designed the study. M.-M.Z. performed the experiments and analyzed data. T.-T.R. supplied reagents and contributed to the analysis of clinical samples. J.-K.W., L.Y., T.-T.L., J.-C.Z., Y.L., and J.-H.X. helped with part of the experiments. L.Y. and D.L. contributed to protein analytical experiments. K.-W.Z. and M.-M.Z. wrote the manuscript. X.-D.T. and P.-F.T. contributed to the experiment design and manuscript editing. All authors reviewed the results and approved the final version of the manuscript.</p></sec><sec sec-type="COI-statement" id="s13"><title>Conflict of interest</title><p>The authors declare no conflict of interest.</p></sec><sec id="s14"><title>Ethics approval</title><p>All animal experiments were performed in accordance with institutional and governmental regulations regarding the ethical use of animals, and were approved by the Ethical Institutional Animal Care and Use Committee of Peking University (Approval Number: LA2021544). The use of human osteosarcoma tissue samples was approved by the Research Ethics Committee of Peking University People&#x02019;s Hospital (2020PHB369-01).</p></sec><sec id="s15"><title>Consent to participate</title><p>All authors give their consent to participate.</p></sec><sec id="s16"><title>Consent for publication</title><p>All authors give their consent to publication.</p></sec><sec id="s17"><title>Funding</title><p>This work was financially supported by National Natural Sciences Foundation of China (82325050), National Key R&#x00026;D Program of China (2022YFC3501601), Beijing Municipal Natural Science Foundation (7232273), Jinan New 20 Policies for Higher Education Funding (202228048), and Natural Science Foundation of Shandong Province (Joint Foundation for Innovation and Development) (ZR2022LZY021).</p></sec><sec sec-type="data-availability" id="s18"><title>Data availability</title><p>The main data supporting the results in the study are available within the paper and its <xref rid="sup1" ref-type="supplementary-material">Supplementary Information</xref>. The raw and processed datasets generated during the current study are available for research purposes from the corresponding authors upon reasonable request.</p></sec><sec id="s19"><title>Code availability</title><p>Not applicable.</p></sec><ref-list id="r1"><title>References</title><ref id="CIT0001"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Adachi</surname>
<given-names>S</given-names>
</string-name>, <string-name><surname>Nagao</surname><given-names>T</given-names></string-name>, <string-name><surname>Ingolfsson</surname><given-names>HI</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells</article-title>. <source>Cancer Res</source><year>2007</year>;<volume>67</volume>:<fpage>6493</fpage>&#x02013;<lpage>6501</lpage>.<pub-id pub-id-type="pmid">17616711</pub-id>
</mixed-citation></ref><ref id="CIT0002"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Breeze</surname>
<given-names>E</given-names>
</string-name>, <string-name><surname>Dzimitrowicz</surname><given-names>N</given-names></string-name>, <string-name><surname>Kriechbaumer</surname><given-names>V</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>A C-terminal amphipathic helix is necessary for the <italic toggle="yes">in vivo</italic> tubule-shaping function of a plant reticulon</article-title>. <source>Proc Natl Acad Sci U S A</source><year>2016</year>;<volume>113</volume>:<fpage>10902</fpage>&#x02013;<lpage>10907</lpage>.<pub-id pub-id-type="pmid">27621477</pub-id>
</mixed-citation></ref><ref id="CIT0003"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Carlson</surname>
<given-names>SM</given-names>
</string-name>, <string-name><surname>White</surname><given-names>FM.</given-names></string-name></person-group>
<article-title>Using small molecules and chemical genetics to interrogate signaling networks</article-title>. <source>ACS Chem Biol</source><year>2011</year>;<volume>6</volume>:<fpage>75</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="pmid">21077690</pub-id>
</mixed-citation></ref><ref id="CIT0004"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Carter</surname>
<given-names>RJ</given-names>
</string-name>, <string-name><surname>Milani</surname><given-names>M</given-names></string-name>, <string-name><surname>Beckett</surname><given-names>AJ</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Novel roles of RTN4 and CLIMP-63 in regulating mitochondrial structure, bioenergetics and apoptosis</article-title>. <source>Cell Death Dis</source><year>2022</year>;<volume>13</volume>:<fpage>436</fpage>.<pub-id pub-id-type="pmid">35508606</pub-id>
</mixed-citation></ref><ref id="CIT0005"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name><surname>He</surname><given-names>WT</given-names></string-name>, <string-name><surname>Hu</surname><given-names>L</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis</article-title>. <source>Cell Res</source><year>2016</year>;<volume>26</volume>:<fpage>1007</fpage>&#x02013;<lpage>1020</lpage>.<pub-id pub-id-type="pmid">27573174</pub-id>
</mixed-citation></ref><ref id="CIT0006"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chen</surname>
<given-names>G</given-names>
</string-name>, <string-name><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname><given-names>W</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Bioactivity and pharmacological properties of &#x003b1;-mangostin from the mangosteen fruit: a review</article-title>. <source>Expert Opin Ther Pat</source><year>2018</year>;<volume>28</volume>:<fpage>415</fpage>&#x02013;<lpage>427</lpage>.<pub-id pub-id-type="pmid">29558225</pub-id>
</mixed-citation></ref><ref id="CIT0007"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name><surname>Guo</surname><given-names>X</given-names></string-name>, <string-name><surname>Ge</surname><given-names>Q</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>ER stress activates the NLRP3 inflammasome: a novel mechanism of atherosclerosis</article-title>. <source>Oxid Med Cell Longev</source><year>2019</year>;<volume>2019</volume>:<fpage>3462530</fpage>.<pub-id pub-id-type="pmid">31687078</pub-id>
</mixed-citation></ref><ref id="CIT0008"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Collins</surname>
<given-names>RN.</given-names>
</string-name>
</person-group>
<article-title>How the ER stays in shape</article-title>. <source>Cell</source><year>2006</year>;<volume>124</volume>:<fpage>464</fpage>&#x02013;<lpage>466</lpage>.<pub-id pub-id-type="pmid">16469692</pub-id>
</mixed-citation></ref><ref id="CIT0009"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Diekmann</surname>
<given-names>H</given-names>
</string-name>, <string-name><surname>Klinger</surname><given-names>M</given-names></string-name>, <string-name><surname>Oertle</surname><given-names>T</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Analysis of the reticulon gene family demonstrates the absence of the neurite growth inhibitor Nogo-A in fish</article-title>. <source>Mol Biol Evol</source><year>2005</year>;<volume>22</volume>:<fpage>1635</fpage>&#x02013;<lpage>1648</lpage>.<pub-id pub-id-type="pmid">15858203</pub-id>
</mixed-citation></ref><ref id="CIT0010"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gangadhar</surname>
<given-names>NM</given-names>
</string-name>, <string-name><surname>Stockwell</surname><given-names>BR.</given-names></string-name></person-group>
<article-title>Chemical genetic approaches to probing cell death</article-title>. <source>Curr Opin Chem Biol</source><year>2007</year>;<volume>11</volume>:<fpage>83</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="pmid">17174591</pub-id>
</mixed-citation></ref><ref id="CIT0011"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hetz</surname>
<given-names>C</given-names>
</string-name>, <string-name><surname>Papa</surname><given-names>FR.</given-names></string-name></person-group>
<article-title>The unfolded protein response and cell fate control</article-title>. <source>Mol Cell</source><year>2018</year>;<volume>69</volume>:<fpage>169</fpage>&#x02013;<lpage>181</lpage>.<pub-id pub-id-type="pmid">29107536</pub-id>
</mixed-citation></ref><ref id="CIT0012"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hu</surname>
<given-names>L</given-names>
</string-name>, <string-name><surname>Chen</surname><given-names>M</given-names></string-name>, <string-name><surname>Chen</surname><given-names>X</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Chemotherapy-induced pyroptosis is mediated by BAK/BAX-caspase-3-GSDME pathway and inhibited by 2-bromopalmitate</article-title>. <source>Cell Death Dis</source><year>2020</year>;<volume>11</volume>:<fpage>281</fpage>.<pub-id pub-id-type="pmid">32332857</pub-id>
</mixed-citation></ref><ref id="CIT0013"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Joshi</surname>
<given-names>AS</given-names>
</string-name>, <string-name><surname>Huang</surname><given-names>X</given-names></string-name>, <string-name><surname>Choudhary</surname><given-names>V</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>A family of membrane-shaping proteins at ER subdomains regulates pre-peroxisomal vesicle biogenesis</article-title>. <source>J Cell Biol</source><year>2016</year>;<volume>215</volume>:<fpage>515</fpage>&#x02013;<lpage>529</lpage>.<pub-id pub-id-type="pmid">27872254</pub-id>
</mixed-citation></ref><ref id="CIT0014"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kamoshima</surname>
<given-names>Y</given-names>
</string-name>, <string-name><surname>Terasaka</surname><given-names>S</given-names></string-name>, <string-name><surname>Kuroda</surname><given-names>S</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Morphological and histological changes of glioma cells immediately after 5-aminolevulinic acid mediated photodynamic therapy</article-title>. <source>Neurol Res</source><year>2011</year>;<volume>33</volume>:<fpage>739</fpage>&#x02013;<lpage>746</lpage>.<pub-id pub-id-type="pmid">21756554</pub-id>
</mixed-citation></ref><ref id="CIT0015"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kayagaki</surname>
<given-names>N</given-names>
</string-name>, <string-name><surname>Kornfeld</surname><given-names>OS</given-names></string-name>, <string-name><surname>Lee</surname><given-names>BL</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>NINJ1 mediates plasma membrane rupture during lytic cell death</article-title>. <source>Nature</source><year>2021</year>;<volume>591</volume>:<fpage>131</fpage>&#x02013;<lpage>136</lpage>.<pub-id pub-id-type="pmid">33472215</pub-id>
</mixed-citation></ref><ref id="CIT0016"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ke</surname>
<given-names>R</given-names>
</string-name>, <string-name><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Hong</surname><given-names>S</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Endoplasmic reticulum stress related factor IRE1&#x003b1; regulates TXNIP/NLRP3-mediated pyroptosis in diabetic nephropathy</article-title>. <source>Exp Cell Res</source><year>2020</year>;<volume>396</volume>:<fpage>112293</fpage>.<pub-id pub-id-type="pmid">32950473</pub-id>
</mixed-citation></ref><ref id="CIT0017"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kim</surname>
<given-names>HJ</given-names>
</string-name>, <string-name><surname>Fei</surname><given-names>X</given-names></string-name>, <string-name><surname>Cho</surname><given-names>SC</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Discovery of &#x003b1;-mangostin as a novel competitive inhibitor against mutant isocitrate dehydrogenase-1</article-title>. <source>Bioorg Med Chem Lett</source><year>2015</year>;<volume>25</volume>:<fpage>5625</fpage>&#x02013;<lpage>5631</lpage>.<pub-id pub-id-type="pmid">26508549</pub-id>
</mixed-citation></ref><ref id="CIT0018"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kiseleva</surname>
<given-names>E</given-names>
</string-name>, <string-name><surname>Morozova</surname><given-names>KN</given-names></string-name>, <string-name><surname>Voeltz</surname><given-names>GK</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Reticulon 4a/NogoA locates to regions of high membrane curvature and may have a role in nuclear envelope growth</article-title>. <source>J Struct Biol</source><year>2007</year>;<volume>160</volume>:<fpage>224</fpage>&#x02013;<lpage>235</lpage>.<pub-id pub-id-type="pmid">17889556</pub-id>
</mixed-citation></ref><ref id="CIT0019"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kuang</surname>
<given-names>E</given-names>
</string-name>, <string-name><surname>Wan</surname><given-names>Q</given-names></string-name>, <string-name><surname>Li</surname><given-names>X</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>ER stress triggers apoptosis induced by Nogo-B/ASY overexpression</article-title>. <source>Exp Cell Res</source><year>2006</year>;<volume>312</volume>:<fpage>1983</fpage>&#x02013;<lpage>1988</lpage>.<pub-id pub-id-type="pmid">16687140</pub-id>
</mixed-citation></ref><ref id="CIT0020"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kumar</surname>
<given-names>D</given-names>
</string-name>, <string-name><surname>Lak</surname><given-names>B</given-names></string-name>, <string-name><surname>Suntio</surname><given-names>T</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>RTN4B interacting protein FAM134C promotes ER membrane curvature and has a functional role in autophagy</article-title>. <source>Mol Biol Cell</source><year>2021</year>;<volume>32</volume>:<fpage>1158</fpage>&#x02013;<lpage>1170</lpage>.<pub-id pub-id-type="pmid">33826365</pub-id>
</mixed-citation></ref><ref id="CIT0021"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lebeaupin</surname>
<given-names>C</given-names>
</string-name>, <string-name><surname>Proics</surname><given-names>E</given-names></string-name>, <string-name><surname>de Bieville</surname><given-names>CH</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>ER stress induces NLRP3 inflammasome activation and hepatocyte death</article-title>. <source>Cell Death Dis</source><year>2015</year>;<volume>6</volume>:<fpage>1879</fpage>.</mixed-citation></ref><ref id="CIT0022"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Li</surname>
<given-names>W</given-names>
</string-name>, <string-name><surname>Deng</surname><given-names>M</given-names></string-name>, <string-name><surname>Loughran</surname><given-names>PA</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>LPS induces active HMGB1 release from hepatocytes into exosomes through the coordinated activities of TLR4 and caspase-11/GSDMD signaling</article-title>. <source>Front Immunol</source><year>2020</year>;<volume>11</volume>:<fpage>229</fpage>.<pub-id pub-id-type="pmid">32328059</pub-id>
</mixed-citation></ref><ref id="CIT0023"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Li</surname>
<given-names>L</given-names>
</string-name>, <string-name><surname>Song</surname><given-names>D</given-names></string-name>, <string-name><surname>Qi</surname><given-names>L</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2/caspase-8/caspase-3/GSDME axis</article-title>. <source>Cancer Lett</source><year>2021a</year>;<volume>520</volume>:<fpage>143</fpage>&#x02013;<lpage>159</lpage>.<pub-id pub-id-type="pmid">34256094</pub-id>
</mixed-citation></ref><ref id="CIT0024"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Li</surname>
<given-names>M</given-names>
</string-name>, <string-name><surname>Lu</surname><given-names>H</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Pyruvate kinase M2 (PKM2) interacts with activating transcription factor 2 (ATF2) to bridge glycolysis and pyroptosis in microglia</article-title>. <source>Mol Immunol</source><year>2021b</year>;<volume>140</volume>:<fpage>250</fpage>&#x02013;<lpage>266</lpage>.<pub-id pub-id-type="pmid">34798593</pub-id>
</mixed-citation></ref><ref id="CIT0025"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lin</surname>
<given-names>JH</given-names>
</string-name>, <string-name><surname>Li</surname><given-names>H</given-names></string-name>, <string-name><surname>Yasumura</surname><given-names>D</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>IRE1 signaling affects cell fate during the unfolded protein response</article-title>. <source>Science</source><year>2007</year>;<volume>318</volume>:<fpage>944</fpage>&#x02013;<lpage>949</lpage>.<pub-id pub-id-type="pmid">17991856</pub-id>
</mixed-citation></ref><ref id="CIT0026"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name><surname>Zhong</surname><given-names>Y</given-names></string-name>, <string-name><surname>Liu</surname><given-names>H</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Oncostatin M sensitizes keratinocytes to UVB-induced inflammation via GSDME-mediated pyroptosis</article-title>. <source>J Dermatol Sci</source><year>2021</year>;<volume>104</volume>:<fpage>95</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="pmid">34674925</pub-id>
</mixed-citation></ref><ref id="CIT0027"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lorenzo</surname>
<given-names>AD</given-names>
</string-name>, <string-name><surname>Manes</surname><given-names>TD</given-names></string-name>, <string-name><surname>Davalos</surname><given-names>A</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Endothelial reticulon-4B (Nogo-B) regulates ICAM-1-mediated leukocyte transmigration and acute inflammation</article-title>. <source>Blood</source><year>2011</year>;<volume>117</volume>:<fpage>2284</fpage>&#x02013;<lpage>2295</lpage>.<pub-id pub-id-type="pmid">21183689</pub-id>
</mixed-citation></ref><ref id="CIT0028"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Loveless</surname>
<given-names>R</given-names>
</string-name>, <string-name><surname>Bloomquist</surname><given-names>R</given-names></string-name>, <string-name><surname>Teng</surname><given-names>Y.</given-names></string-name></person-group>
<article-title>Pyroptosis at the forefront of anticancer immunity</article-title>. <source>J Exp Clin Cancer Res</source><year>2021</year>;<volume>40</volume>:<fpage>264</fpage>.<pub-id pub-id-type="pmid">34429144</pub-id>
</mixed-citation></ref><ref id="CIT0029"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mamun</surname>
<given-names>AA</given-names>
</string-name>, <string-name><surname>Shao</surname><given-names>C</given-names></string-name>, <string-name><surname>Geng</surname><given-names>P</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Pyroptosis in diabetic peripheral neuropathy and its therapeutic regulation</article-title>. <source>J Inflamm Res</source><year>2024</year>;<volume>17</volume>:<fpage>3839</fpage>&#x02013;<lpage>3864</lpage>.<pub-id pub-id-type="pmid">38895141</pub-id>
</mixed-citation></ref><ref id="CIT0030"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Oertle</surname>
<given-names>T</given-names>
</string-name>, <string-name><surname>Merkler</surname><given-names>D</given-names></string-name>, <string-name><surname>Schwab</surname><given-names>ME.</given-names></string-name></person-group>
<article-title>Do cancer cells die because of Nogo-B</article-title>? <source>Oncogene</source><year>2003</year>;<volume>22</volume>:<fpage>1390</fpage>&#x02013;<lpage>1399</lpage>.<pub-id pub-id-type="pmid">12618765</pub-id>
</mixed-citation></ref><ref id="CIT0031"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Puhka</surname>
<given-names>M</given-names>
</string-name>, <string-name><surname>Joensuu</surname><given-names>M</given-names></string-name>, <string-name><surname>Vihinen</surname><given-names>H</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Progressive sheet-to-tubule transformation is a general mechanism for endoplasmic reticulum partitioning in dividing mammalian cells</article-title>. <source>Mol Biol Cell</source><year>2012</year>;<volume>23</volume>:<fpage>2424</fpage>&#x02013;<lpage>2432</lpage>.<pub-id pub-id-type="pmid">22573885</pub-id>
</mixed-citation></ref><ref id="CIT0032"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>R&#x000fc;hl</surname>
<given-names>S</given-names>
</string-name>, <string-name><surname>Shkarina</surname><given-names>K</given-names></string-name>, <string-name><surname>Demarco</surname><given-names>B</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation</article-title>. <source>Science</source><year>2018</year>;<volume>362</volume>:<fpage>956</fpage>&#x02013;<lpage>960</lpage>.<pub-id pub-id-type="pmid">30467171</pub-id>
</mixed-citation></ref><ref id="CIT0033"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Shibata</surname>
<given-names>Y</given-names>
</string-name>, <string-name><surname>Voeltz</surname><given-names>GK</given-names></string-name>, <string-name><surname>Rapoport</surname><given-names>TA.</given-names></string-name></person-group>
<article-title>Rough sheets and smooth tubules</article-title>. <source>Cell</source><year>2006</year>;<volume>126</volume>:<fpage>435</fpage>&#x02013;<lpage>439</lpage>.<pub-id pub-id-type="pmid">16901774</pub-id>
</mixed-citation></ref><ref id="CIT0034"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Shibata</surname>
<given-names>Y</given-names>
</string-name>, <string-name><surname>Shemesh</surname><given-names>T</given-names></string-name>, <string-name><surname>Prinz</surname><given-names>WA</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Mechanisms determining the morphology of the peripheral ER</article-title>. <source>Cell</source><year>2010</year>;<volume>143</volume>:<fpage>774</fpage>&#x02013;<lpage>788</lpage>.<pub-id pub-id-type="pmid">21111237</pub-id>
</mixed-citation></ref><ref id="CIT0035"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tall</surname>
<given-names>AR</given-names>
</string-name>, <string-name><surname>Westerterp</surname><given-names>M.</given-names></string-name></person-group>
<article-title>Inflammasomes, neutrophil extracellular traps, and cholesterol</article-title>. <source>J Lipid Res</source><year>2019</year>;<volume>60</volume>:<fpage>721</fpage>&#x02013;<lpage>727</lpage>.<pub-id pub-id-type="pmid">30782961</pub-id>
</mixed-citation></ref><ref id="CIT0036"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Voeltz</surname>
<given-names>GK</given-names>
</string-name>, <string-name><surname>Prinz</surname><given-names>WA</given-names></string-name>, <string-name><surname>Shibata</surname><given-names>Y</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>A class of membrane proteins shaping the tubular endoplasmic reticulum</article-title>. <source>Cell</source><year>2006</year>;<volume>124</volume>:<fpage>573</fpage>&#x02013;<lpage>586</lpage>.<pub-id pub-id-type="pmid">16469703</pub-id>
</mixed-citation></ref><ref id="CIT0037"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name><surname>Gao</surname><given-names>W</given-names></string-name>, <string-name><surname>Shi</surname><given-names>X</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin</article-title>. <source>Nature</source><year>2017</year>;<volume>547</volume>:<fpage>99</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="pmid">28459430</pub-id>
</mixed-citation></ref><ref id="CIT0038"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wang</surname>
<given-names>W</given-names>
</string-name>, <string-name><surname>Hu</surname><given-names>D</given-names></string-name>, <string-name><surname>Wu</surname><given-names>C</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection</article-title>. <source>PLoS Pathog</source><year>2020</year>;<volume>16</volume>:<fpage>e1008335</fpage>.<pub-id pub-id-type="pmid">32187211</pub-id>
</mixed-citation></ref><ref id="CIT0039"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wang</surname>
<given-names>S</given-names>
</string-name>, <string-name><surname>Liu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>L</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Methods for monitoring cancer cell pyroptosis</article-title>. <source>Cancer Biol Med</source><year>2021</year>;<volume>19</volume>:<fpage>398</fpage>&#x02013;<lpage>414</lpage>.<pub-id pub-id-type="pmid">34931767</pub-id>
</mixed-citation></ref><ref id="CIT0040"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Westrate</surname>
<given-names>LM</given-names>
</string-name>, <string-name><surname>Lee</surname><given-names>JE</given-names></string-name>, <string-name><surname>Prinz</surname><given-names>WA</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Form follows function: the importance of endoplasmic reticulum shape</article-title>. <source>Annu Rev Biochem</source><year>2015</year>;<volume>84</volume>:<fpage>791</fpage>&#x02013;<lpage>811</lpage>.<pub-id pub-id-type="pmid">25580528</pub-id>
</mixed-citation></ref><ref id="CIT0041"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wu</surname>
<given-names>H</given-names>
</string-name>, <string-name><surname>Voeltz</surname><given-names>GK.</given-names></string-name></person-group>
<article-title>Reticulon-3 promotes endosome maturation at ER membrane contact sites</article-title>. <source>Dev Cell</source><year>2021</year>;<volume>56</volume>:<fpage>52</fpage>&#x02013;<lpage>66.e7</lpage>.<pub-id pub-id-type="pmid">33434526</pub-id>
</mixed-citation></ref><ref id="CIT0042"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Xiao</surname>
<given-names>P</given-names>
</string-name>, <string-name><surname>Gu</surname><given-names>J</given-names></string-name>, <string-name><surname>Xu</surname><given-names>W</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>RTN4/Nogo-A-S1PR2 negatively regulates angiogenesis and secondary neural repair through enhancing vascular autophagy in the thalamus after cerebral cortical infarction</article-title>. <source>Autophagy</source><year>2022</year>;<volume>18</volume>:<fpage>2711</fpage>&#x02013;<lpage>2730</lpage>.<pub-id pub-id-type="pmid">35263212</pub-id>
</mixed-citation></ref><ref id="CIT0043"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yu</surname>
<given-names>LM</given-names>
</string-name>, <string-name><surname>Zhang</surname><given-names>WH</given-names></string-name>, <string-name><surname>Han</surname><given-names>XX</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Hypoxia-induced ROS contribute to myoblast pyroptosis during obstructive sleep apnea via the NF-&#x003ba;B/HIF-1&#x003b1; signaling pathway</article-title>. <source>Oxid Med Cell Longev</source><year>2019</year>;<volume>2019</volume>:<fpage>4596368</fpage>.<pub-id pub-id-type="pmid">31885794</pub-id>
</mixed-citation></ref><ref id="CIT0044"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yu</surname>
<given-names>P</given-names>
</string-name>, <string-name><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name><surname>Liu</surname><given-names>N</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Pyroptosis: mechanisms and diseases</article-title>. <source>Signal Transduct Target Ther</source><year>2021</year>;<volume>6</volume>:<fpage>128</fpage>.<pub-id pub-id-type="pmid">33776057</pub-id>
</mixed-citation></ref><ref id="CIT0045"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zeng</surname>
<given-names>X</given-names>
</string-name>, <string-name><surname>Zhu</surname><given-names>M</given-names></string-name>, <string-name><surname>Liu</surname><given-names>X</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>Oleic acid ameliorates palmitic acid induced hepatocellular lipotoxicity by inhibition of ER stress and pyroptosis</article-title>. <source>Nutr Metab (Lond)</source><year>2020</year>;<volume>17</volume>:<fpage>11</fpage>.<pub-id pub-id-type="pmid">32021639</pub-id>
</mixed-citation></ref><ref id="CIT0046"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhang</surname>
<given-names>R</given-names>
</string-name>, <string-name><surname>Kang</surname><given-names>R</given-names></string-name>, <string-name><surname>Tang</surname><given-names>D.</given-names></string-name></person-group>
<article-title>The STING1 network regulates autophagy and cell death</article-title>. <source>Signal Transduct Target Ther</source><year>2021</year>;<volume>6</volume>:<fpage>208</fpage>.<pub-id pub-id-type="pmid">34078874</pub-id>
</mixed-citation></ref><ref id="CIT0047"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zheng</surname>
<given-names>Z</given-names>
</string-name>, <string-name><surname>Yang</surname><given-names>S</given-names></string-name>, <string-name><surname>Dai</surname><given-names>W</given-names></string-name></person-group>
<etal>et al</etal>
<article-title>The role of pyroptosis in metabolism and metabolic disease</article-title>. <source>Biomed Pharmacother</source><year>2024</year>;<volume>176</volume>:<fpage>116863</fpage>.<pub-id pub-id-type="pmid">38850650</pub-id>
</mixed-citation></ref></ref-list></back></article>